Comparison of ticagrelor with clopidogrel on quality of life in patients with acute coronary syndrome.
Hyeyeon MoonYoon-Sung JoSoo-Jin KimSua JoKyungil ParkPublished in: Health and quality of life outcomes (2021)
Ticagrelor, as compared to clopidogrel, did not significantly reduce the HQOL during the six months following PCI in patients with ACS. Clinical Trial Registration URL: http://www.clinicaltrials.gov . Unique identifier: NCT02618733.